UniProt O00213
O00213
O00213 (UniProt O00213): 22 experimental structures and 1 predicted model on GenesisL1, 1 ligand bound. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- O00213
- Experimental structures
- 22
- Predicted models
- 1
- Ligands
- 1
Structures
23 records of O00213 in the MolNFT archive: 22 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2E45 | Solution structure of Fe65 WW domain | solution nmr | A | — | — |
| 2E45 | Solution structure of FE65 ww domain | solution nmr | A | — | — |
| 2HO2 | Structure of human FE65-WW domain in complex with hMena peptide. | x-ray diffraction | A | — | — |
| 2HO2 | Structure of human FE65-ww domain in complex with hmena peptide. | x-ray diffraction | A | — | — |
| 2IDH | Crystal Structure of human FE65 WW domain | x-ray diffraction | A, B, C, D, E, F, G, H | — | — |
| 2IDH | Crystal structure of human FE65 ww domain | x-ray diffraction | A, B, C, D, E, F, G, H | — | — |
| 2OEI | Crystal structure of human FE65-WW domain in complex with human Mena peptide | x-ray diffraction | A | — | — |
| 2OEI | Crystal structure of human FE65-ww domain in complex with human mena peptide | x-ray diffraction | A | — | — |
| 3D8D | Crystal structure of the human Fe65-PTB1 domain | x-ray diffraction | A, B | — | — |
| 3D8D | Crystal structure of the human FE65-PTB1 domain | x-ray diffraction | A, B | — | — |
| 3D8E | Crystal structure of the human Fe65-PTB1 domain (trigonal crystal form) | x-ray diffraction | A, B, C, D | — | — |
| 3D8E | Crystal structure of the human FE65-PTB1 domain (trigonal crystal form) | x-ray diffraction | A, B, C, D | — | — |
| 3D8F | Crystal structure of the human Fe65-PTB1 domain with bound phosphate (trigonal crystal form) | x-ray diffraction | A, B, C, D | — | — |
| 3D8F | Crystal structure of the human FE65-PTB1 domain with bound phosphate (trigonal crystal form) | x-ray diffraction | A, B, C, D | — | — |
| 3DXC | Crystal structure of the intracellular domain of human APP in complex with Fe65-PTB2 | x-ray diffraction | A, C | — | — |
| 3DXC | Crystal structure of the intracellular domain of human app in complex with FE65-PTB2 | x-ray diffraction | A, C | — | — |
| 3DXD | Crystal structure of the intracellular domain of human APP (T668E mutant) in complex with Fe65-PTB2 | x-ray diffraction | A, C | — | — |
| 3DXD | Crystal structure of the intracellular domain of human app (T668E mutant) in complex with FE65-PTB2 | x-ray diffraction | A, C | — | — |
| 3DXE | Crystal structure of the intracellular domain of human APP (T668A mutant) in complex with Fe65-PTB2 | x-ray diffraction | A, C | — | — |
| 3DXE | Crystal structure of the intracellular domain of human app (T668A mutant) in complex with FE65-PTB2 | x-ray diffraction | A, C | — | — |
| 5NQH | Structure of the human Fe65-PTB2 homodimer | x-ray diffraction | A, B, C, D | SO4 | — |
| 5NQH | Structure of the human FE65-PTB2 homodimer | x-ray diffraction | A, B, C, D | SO4 | — |
| O00213 | AlphaFold monomer V2.0 prediction for amyloid-beta A4 precursor protein-binding family B member 1… | predicted | A | — | — |
Ligands
- SO4 · Sulfate ion · in 2 records
Experiment against prediction
- 3D8D chain B against the predicted model O00213: TM-score 0.99, RMSD 0.52 Å
- 3D8D chain B against the predicted model O00213: TM-score 0.99, RMSD 0.52 Å
- 3D8E chain B against the predicted model O00213: TM-score 0.98, RMSD 0.59 Å
- 3D8E chain B against the predicted model O00213: TM-score 0.98, RMSD 0.59 Å
- 3D8D chain A against the predicted model O00213: TM-score 0.98, RMSD 0.68 Å
- 3D8D chain A against the predicted model O00213: TM-score 0.98, RMSD 0.68 Å
- 3D8E chain D against the predicted model O00213: TM-score 0.98, RMSD 0.63 Å
- 3D8E chain D against the predicted model O00213: TM-score 0.98, RMSD 0.63 Å
- 3D8E chain C against the predicted model O00213: TM-score 0.98, RMSD 0.68 Å
- 3D8E chain C against the predicted model O00213: TM-score 0.98, RMSD 0.68 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.